CASI PHARMACEUTICALS, INC. (CASIF) Net margin 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) net profit margin by fiscal year — reported net income divided by reported revenue.
-232.0%FY2025 · since FY2020: -321.9% → -232.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -232.0% | -94.5 pp |
| FY2024 | -137.6% | -58.0 pp |
| FY2023 | -79.6% | +28.2 pp |
| FY2022 | -107.8% | +14.3 pp |
| FY2021 | -122.1% | +199.8 pp |
| FY2020 | -321.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice